
Fertility Preservation in Pediatric Oncology Patients
Pediatric oncology patients often require chemotherapy and/or radiation therapy that carries a high risk of infertility. Fertility preservation options include sperm banking, testicular tissue preservation, ovarian tissue preservation, egg harvesting, testicular/ovarian shielding, ovarian transposition and gonadotropinreleasing hormone agonist therapy. It is standard of care to review fertility preservation options with patients prior to undergoing fertility endangering therapy.
The aim of this project is to provide every oncology patient the opportunity to have fertility preservation if clinically appropriate. Specific objectives include to have 100% of patients offered fertility preservation, to have 50% of patients receive fertility preservation, and to have 100% of providers feel comfortable discussing fertility preservation options within one year of the start of this project.
Target Audience
Learning Objectives
- To provide every oncology patient the opportunity to have fertility preservation if clinically appropriate.
Specific objectives include:- Offer fertility preservation to 100% of eligible pediatric hematology/oncology patients by January 1, 2020.
- Have 50% of eligible pediatric hematology/oncology patients receive fertility preservation by January 1, 2020.
- To have 100% of pediatric hematology/oncology providers feel comfortable discussing and referring for fertility preservation options by January 1, 2020.
- 20.00 AMA PRA Category 1 Credit™
- 20.00 Participation

WANT TO KNOW MORE?
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Ami Siddiqui via e-mail at [email protected].
QI/PI PROJECT LEADERS
Associate Professor of Pediatrics
Director, Fellowship Program
The University of Chicago
Fellow, Pediatric Hematology/Oncology
The University of Chicago
Fellow, Pediatric Hematology/Oncology
The University of Chicago
Pediatric Hematology/Oncology
The University of Chicago
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine designates this PI CME activity for a maximum of 20 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses and other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
The national Multi-Specialty MOC Portfolio Approval Program has granted approval to the University of Chicago to award MOC Part IV credit to physicians participating in quality improvement (QI) projects. To qualify for both PI CME credit (AMA PRA Category 1 Credit™) and QI MOC through the ABMS Multi-specialty Portfolio Program, participants must be engaged in a systematic effort of reviewing and improving some aspect(s) of care or care delivery for their patients.
Sustained QI Cycles: Physicians are required to complete not less than 2 intervention cycles and not less than 3 data collection points:
1st QI cycle
Baseline data collection, analysis/review, identify underlying cause(s)
Intervention(s) to address underlying cause(s)
Post-intervention data collection, analysis/review, identify remaining underlying cause(s)
Post-intervention data collection, analysis/review, identify underlying cause(s) (same as above)
Adjustment(s) / second intervention(s) to address underlying cause(s)
Post-adjustment data collection, analysis/review, identify remaining underlying cause(s)
Attestation forms must be submitted by November 30th in order for us to report credit to your ABMS specialty board and have your credit count for that year.
Claiming Credit: Enter the access code to unlock the credit claiming process.